Corrigendum: Metabolic Dependencies in Pancreatic Cancer

Ali Vaziri-Gohar¹, Mahsa Zarei^{2

3}, Jonathan R Brody⁴, Jordan M Winter^{1

5}

Affiliations

¹ School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
² Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, United States.
³ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
⁴ Division of Surgical Research, Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
⁵ Department of Surgery and Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.

Published Erratum

Ali Vaziri-Gohar et al. Front Oncol. 2019.

. 2019 Jan 31:8:672.

doi: 10.3389/fonc.2018.00672. eCollection 2018.

Ali Vaziri-Gohar¹, Mahsa Zarei^{2

3}, Jonathan R Brody⁴, Jordan M Winter^{1

5}

¹ School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
² Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, United States.
³ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
⁴ Division of Surgical Research, Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
⁵ Department of Surgery and Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.

Abstract

[This corrects the article DOI: 10.3389/fonc.2018.00617.].

Keywords: metabolic dependencies; metabolism; pancreatic cancer; redox homeostasis; targeting metabolism.

Metabolic Dependencies in Pancreatic Cancer.
Vaziri-Gohar A, Zarei M, Brody JR, Winter JM. Vaziri-Gohar A, et al. Front Oncol. 2018 Dec 12;8:617. doi: 10.3389/fonc.2018.00617. eCollection 2018. Front Oncol. 2018. PMID: 30631752 Free PMC article. Review.

1. Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature (2013) 497:633–7. 10.1038/nature12138 - DOI - PMC - PubMed
1. Zarei M, Lal S, Parker SJ, Nevler A, Vaziri-Gohar A, Dukleska K, et al. Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells. Cancer Res. (2017) 77:4460–71. 10.1158/0008-5472.CAN-17-0015 - DOI - PMC - PubMed
1. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 496:101–5. 10.1038/nature12040 - DOI - PMC - PubMed
1. Rambold AS, Kostelecky B, Elia N, Lippincott-Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci USA. (2011) 108:10190–5. 10.1073/pnas.1107402108 - DOI - PMC - PubMed
1. Kordes S, Pollak MN, Zwinderman AH, Mathot RA, Weterman MJ, Beeker A, et al. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. (2015) 16:839–47. 10.1016/S1470-2045(15)00027-3 - DOI - PubMed